quofenix
a. menarini industrie farmaceutiche riunite s.r.l. - delafloxacin meglúmíni - samfarir í bandalaginu - sýklalyf fyrir almenn nota, - quofenix is indicated for the treatment of the following infections in adults:acute bacterial skin and skin structure infections (absssi),community-acquired pneumonia (cap), when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the initial treatment of these infections (see sections 4. 4 og 5. Íhuga ætti að opinbera leiðsögn á réttri notkun af sýklalyfjum.
malastad filmuhúðuð tafla 250/100mg mg
stada arzneimittel ag - atovaquonum inn; proguanilum hýdróklóríð - filmuhúðuð tafla - 250/100mg mg
malarone filmuhúðuð tafla 250/100 mg
glaxosmithkline pharma a/s - atovaquonum inn; proguanilum hýdróklóríð - filmuhúðuð tafla - 250/100 mg
eqvalan duo vet. pasta til inntöku
boehringer ingelheim animal health france scs - ivermectinum inn; praziquantelum inn - pasta til inntöku
eqvalan vet. pasta til inntöku 1,87 %
boehringer ingelheim animal health france scs - ivermectinum inn - pasta til inntöku - 1,87 %
afipran stungulyf, lausn 5 mg/ml
orifarm healthcare a/s - metoclopramidum hýdróklóríð - stungulyf, lausn - 5 mg/ml
afipran tafla 10 mg
orifarm healthcare a/s - metoclopramidum hýdróklóríð - tafla - 10 mg
nematel vet. (twinhip vet.) pasta til inntöku 439 mg/g
le vet beheer b.v. - pyrantelum embónat - pasta til inntöku - 439 mg/g
doxycyklin eql pharma tafla 100 mg
eql pharma ab - doxycyclinum inn - tafla - 100 mg
rimactan hart hylki 300 mg
sandoz gmbh* - rifampicinum inn - hart hylki - 300 mg